Aurora Cannabis Inc. (ACB) vs SAB Biotherapeutics, Inc. (SABS)
A side-by-side comparison of Aurora Cannabis Inc. and SAB Biotherapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACB
Aurora Cannabis Inc.
$4.54HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
SABS
SAB Biotherapeutics, Inc.
$2.96HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
Total return — ACB vs SABS
growth of $100 · dividends reinvested · last 6yACB -97.0% (-44.3%/yr)SABS -96.9% (-44.1%/yr)SABS compounded faster over this window
ACB SABS
ACB vs SABS: by the numbers
- •ACB is the larger company ($281M vs $269M market cap).
- •Both run net losses; SABS's is the smaller (0.00% vs -38.13% net margin).
Metrics side by side
Valuation
| Metric | ACB | SABS |
|---|---|---|
| P/S ratio | 1.35 | N/A |
| P/B ratio | 0.76 | 1.25 |
Profitability
| Metric | ACB | SABS |
|---|---|---|
| Gross margin | 42.62% | 0.00% |
| Operating margin | -14.55% | 0.00% |
| Net margin | -38.13% | 0.00% |
| ROE | -21.41% | -5.95% |
| ROIC | -15.69% | -31.62% |
Growth (annualized)
| Metric | ACB | SABS |
|---|---|---|
| Revenue CAGR (5Y) | 1.68% | N/A |
| EPS CAGR (5Y) | N/A | -50.57% |
| Total return CAGR (5Y) | -42.83% | -50.16% |
Frequently asked
- How have ACB and SABS total returns compared?
- Over the past 5 years, ACB delivered -42.83% and SABS delivered -50.16% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.